Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for VCEL

Stock NameVericel Corp Ord
TickerVCEL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92346J1088
LEI54930076YM3PLTDR4B91

Show aggregate VCEL holdings

News associated with VCEL

BTIG Research Downgrades Vericel (NASDAQ:VCEL) to Neutral
Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by BTIG Research from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, MarketBeat.com reports. VCEL has been the subject of a number of other research reports. Stephens reiterated an “overweight” rating and issued a $67.00 price objective on shares of […] - 2025-09-19 02:50:54
Vericel (NASDAQ:VCEL) Shares Gap Down Following Analyst Downgrade
Vericel Corporation (NASDAQ:VCEL – Get Free Report)’s share price gapped down prior to trading on Wednesday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The stock had previously closed at $33.23, but opened at $31.85. Vericel shares last traded at $31.15, with a volume of 120,872 shares. A number […] - 2025-09-19 02:18:56
Vericel (NASDAQ:VCEL) Reaches New 52-Week Low on Analyst Downgrade
Vericel Corporation (NASDAQ:VCEL – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The company traded as low as $29.93 and last traded at $30.02, with a volume of 1683483 shares traded. The stock had previously closed […] - 2025-09-18 03:06:42
Vericel Corporation (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Brokerages
Vericel Corporation (NASDAQ:VCEL – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have covered the stock in the last year […] - 2025-08-21 04:24:45
Maryland State Retirement & Pension System Cuts Holdings in Vericel Corporation (NASDAQ:VCEL)
Maryland State Retirement & Pension System trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 13.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,387 shares of the biotechnology company’s stock after selling 2,170 shares during the […] - 2025-08-14 05:17:00
Vericel Corporation (NASDAQ:VCEL) Shares Bought by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC grew its stake in Vericel Corporation (NASDAQ:VCEL – Free Report) by 5.9% during the 1st quarter, Holdings Channel reports. The fund owned 158,930 shares of the biotechnology company’s stock after acquiring an additional 8,789 shares during the period. Mutual of America Capital Management LLC’s holdings in Vericel were worth […] - 2025-08-08 04:30:54
Geneva Capital Management LLC Has $60.94 Million Stock Holdings in Vericel Corporation (NASDAQ:VCEL)
Geneva Capital Management LLC grew its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 24.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,365,744 shares of the biotechnology company’s stock after purchasing an additional 265,956 shares during the quarter. Vericel […] - 2025-08-04 04:28:58
Envestnet Asset Management Inc. Raises Stock Position in Vericel Corporation (NASDAQ:VCEL)
Envestnet Asset Management Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 15.6% during the first quarter, Holdings Channel reports. The institutional investor owned 204,510 shares of the biotechnology company’s stock after buying an additional 27,526 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Vericel were worth $9,125,000 as of […] - 2025-07-22 06:48:58
Principal Financial Group Inc. Grows Stake in Vericel Corporation (NASDAQ:VCEL)
Principal Financial Group Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.7% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 270,154 shares of the biotechnology company’s stock after purchasing an additional 7,222 shares during the period. Principal Financial Group Inc.’s holdings in Vericel were worth $12,054,000 as of its […] - 2025-07-14 04:52:59
Vericel Corporation (NASDAQ:VCEL) Shares Sold by Amalgamated Bank
Amalgamated Bank trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,010 shares of the biotechnology company’s stock after selling 375 shares during the quarter. Amalgamated […] - 2025-07-10 04:40:59
Oregon Public Employees Retirement Fund Cuts Holdings in Vericel Corporation (NASDAQ:VCEL)
Oregon Public Employees Retirement Fund decreased its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% in the first quarter, Holdings Channel reports. The institutional investor owned 11,293 shares of the biotechnology company’s stock after selling 300 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Vericel were worth $504,000 as of […] - 2025-07-08 05:24:54
Allspring Global Investments Holdings LLC Reduces Holdings in Vericel Corporation (NASDAQ:VCEL)
Allspring Global Investments Holdings LLC trimmed its position in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 4.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 249,441 shares of the biotechnology company’s stock after selling 11,632 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Vericel were worth $10,747,000 […] - 2025-07-04 04:52:25
Vericel Corporation (NASDAQ:VCEL) Given Average Rating of “Buy” by Brokerages
Shares of Vericel Corporation (NASDAQ:VCEL – Get Free Report) have been assigned an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have updated their coverage on […] - 2025-07-02 05:08:59
Vericel (NASDAQ:VCEL) Receives Overweight Rating from Stephens
Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued on Monday,Benzinga reports. They presently have a $67.00 price objective on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 61.45% from the company’s previous close. A number of […] - 2025-06-18 03:02:52
GAMMA Investing LLC Has $5.76 Million Position in Vericel Co. (NASDAQ:VCEL)
GAMMA Investing LLC raised its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5,916.5% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 129,175 shares of the biotechnology company’s stock after purchasing an additional 127,028 shares during the quarter. GAMMA Investing LLC’s holdings in Vericel were worth $5,764,000 at the […] - 2025-06-10 04:38:49
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $61.14
Vericel Co. (NASDAQ:VCEL – Get Free Report) has been assigned a consensus rating of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in the last year […] - 2025-06-10 03:14:49
Mackenzie Financial Corp Acquires New Stake in Vericel Co. (NASDAQ:VCEL)
Mackenzie Financial Corp bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 3,924 shares of the biotechnology company’s stock, valued at approximately $215,000. A number of other hedge funds and other institutional investors also recently bought and sold shares of VCEL. […] - 2025-06-06 04:50:53
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Deutsche Bank AG
Deutsche Bank AG grew its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 32.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 52,999 shares of the biotechnology company’s stock after buying an additional 12,890 shares during the quarter. Deutsche Bank AG’s holdings in Vericel were worth $2,910,000 as of its most recent SEC […] - 2025-05-22 04:45:02
BNP Paribas Financial Markets Reduces Stake in Vericel Co. (NASDAQ:VCEL)
BNP Paribas Financial Markets lowered its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 35.1% in the 4th quarter, Holdings Channel reports. The fund owned 20,699 shares of the biotechnology company’s stock after selling 11,202 shares during the quarter. BNP Paribas Financial Markets’ holdings in Vericel were worth $1,137,000 as of its most recent […] - 2025-05-21 04:30:48
Vericel (NASDAQ:VCEL) Rating Lowered to “Sell” at StockNews.com
Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Monday. VCEL has been the topic of a number of other research reports. Stephens reaffirmed an “overweight” rating and set a $65.00 target price on shares of Vericel […] - 2025-05-14 02:14:47
The Manufacturers Life Insurance Company Sells 526 Shares of Vericel Co. (NASDAQ:VCEL)
The Manufacturers Life Insurance Company lowered its position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,593 shares of the biotechnology company’s stock after selling 526 shares during […] - 2025-05-13 05:22:54
Price T Rowe Associates Inc. MD Decreases Stake in Vericel Co. (NASDAQ:VCEL)
Price T Rowe Associates Inc. MD lowered its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 2.9% during the fourth quarter, HoldingsChannel reports. The fund owned 29,479 shares of the biotechnology company’s stock after selling 868 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Vericel were worth $1,619,000 as of […] - 2025-05-09 05:47:10
Vericel Co. (NASDAQ:VCEL) Stock Position Boosted by Mariner LLC
Mariner LLC grew its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,209 shares of the biotechnology company’s stock after acquiring an additional 659 shares during the period. Mariner LLC’s holdings in Vericel were worth $506,000 at the end of […] - 2025-05-02 05:09:04
Renaissance Technologies LLC Buys 9,200 Shares of Vericel Co. (NASDAQ:VCEL)
Renaissance Technologies LLC increased its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 11.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 89,500 shares of the biotechnology company’s stock after purchasing an additional 9,200 shares during the period. Renaissance Technologies LLC’s […] - 2025-04-21 04:46:48
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $60.86
Vericel Co. (NASDAQ:VCEL – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have covered the stock in the last year is […] - 2025-04-21 02:30:46
Alliancebernstein L.P. Reduces Stake in Vericel Co. (NASDAQ:VCEL)
Alliancebernstein L.P. reduced its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5.5% in the fourth quarter, Holdings Channel reports. The fund owned 54,730 shares of the biotechnology company’s stock after selling 3,160 shares during the quarter. Alliancebernstein L.P.’s holdings in Vericel were worth $3,005,000 as of its most recent filing with […] - 2025-04-16 04:31:00
Vericel Co. (NASDAQ:VCEL) Shares Sold by Sei Investments Co.
Sei Investments Co. cut its stake in Vericel Co. (NASDAQ:VCEL – Free Report) by 8.2% in the fourth quarter, Holdings Channel reports. The firm owned 59,945 shares of the biotechnology company’s stock after selling 5,320 shares during the period. Sei Investments Co.’s holdings in Vericel were worth $3,291,000 as of its most recent filing with […] - 2025-04-04 06:28:59
Vericel Co. (NASDAQ:VCEL) Stake Reduced by Corebridge Financial Inc.
Corebridge Financial Inc. trimmed its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,155 shares of the biotechnology company’s stock after selling 1,682 shares during the quarter. Corebridge Financial Inc.’s holdings in Vericel […] - 2025-04-04 05:41:01
Prudential Financial Inc. Sells 4,199 Shares of Vericel Co. (NASDAQ:VCEL)
Prudential Financial Inc. decreased its holdings in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,004 shares of the biotechnology company’s stock after selling 4,199 shares during the period. […] - 2025-04-04 04:31:04
Avantax Advisory Services Inc. Purchases 234 Shares of Vericel Co. (NASDAQ:VCEL)
Avantax Advisory Services Inc. boosted its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 1.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,803 shares of the biotechnology company’s stock after acquiring an additional 234 shares during the period. Avantax […] - 2025-03-21 06:47:07

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) VCEL holdings

DateNumber of VCEL Shares HeldBase Market Value of VCEL SharesLocal Market Value of VCEL SharesChange in VCEL Shares HeldChange in VCEL Base ValueCurrent Price per VCEL Share HeldPrevious Price per VCEL Share Held
2025-11-11 (Tuesday)32,386USD 1,329,445VCEL holding increased by 66715USD 1,329,4450USD 66,715 USD 41.05 USD 38.99
2025-11-10 (Monday)32,386VCEL holding increased by 83USD 1,262,730VCEL holding increased by 4851USD 1,262,73083USD 4,851 USD 38.99 USD 38.94
2025-11-07 (Friday)32,303USD 1,257,879VCEL holding increased by 6138USD 1,257,8790USD 6,138 USD 38.94 USD 38.75
2025-11-06 (Thursday)32,303VCEL holding increased by 83USD 1,251,741VCEL holding increased by 53157USD 1,251,74183USD 53,157 USD 38.75 USD 37.2
2025-11-05 (Wednesday)32,220USD 1,198,584VCEL holding increased by 30609USD 1,198,5840USD 30,609 USD 37.2 USD 36.25
2025-11-04 (Tuesday)32,220VCEL holding increased by 83USD 1,167,975VCEL holding decreased by -11614USD 1,167,97583USD -11,614 USD 36.25 USD 36.705
2025-11-03 (Monday)32,137USD 1,179,589VCEL holding increased by 52866USD 1,179,5890USD 52,866 USD 36.705 USD 35.06
2025-10-31 (Friday)32,137USD 1,126,723VCEL holding increased by 17032USD 1,126,7230USD 17,032 USD 35.06 USD 34.53
2025-10-30 (Thursday)32,137VCEL holding increased by 415USD 1,109,691VCEL holding increased by 3228USD 1,109,691415USD 3,228 USD 34.53 USD 34.88
2025-10-29 (Wednesday)31,722VCEL holding increased by 166USD 1,106,463VCEL holding decreased by -55744USD 1,106,463166USD -55,744 USD 34.88 USD 36.83
2025-10-28 (Tuesday)31,556USD 1,162,207VCEL holding increased by 11360USD 1,162,2070USD 11,360 USD 36.83 USD 36.47
2025-10-27 (Monday)31,556USD 1,150,847VCEL holding increased by 4733USD 1,150,8470USD 4,733 USD 36.47 USD 36.32
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VCEL by Blackrock for IE00BYXG2H39

Show aggregate share trades of VCEL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY83 38.990* 44.57
2025-11-06BUY83 38.750* 44.62
2025-11-04BUY83 36.250* 44.71
2025-10-30BUY415 34.530* 44.85
2025-10-29BUY16634.88036.990 36.779USD 6,105 44.90
2025-10-22SELL-33236.43036.830 36.790USD -12,214 45.13 Profit of 2,770 on sale
2025-10-20BUY16636.02036.500 36.452USD 6,051 45.23
2025-10-17BUY41535.32035.320 35.320USD 14,658 45.29
2025-10-15BUY66433.59035.050 34.904USD 23,176 45.35
2025-10-03BUY58132.44033.240 33.160USD 19,266 45.48
2025-10-02BUY8331.52031.580 31.574USD 2,621 45.56
2025-09-30BUY16631.47031.980 31.929USD 5,300 45.72
2025-09-26BUY16630.23030.440 30.419USD 5,050 45.89
2025-09-25BUY16629.84030.000 29.984USD 4,977 45.99
2025-09-24SELL-1,86130.25031.470 31.348USD -58,339 46.08 Profit of 27,411 on sale
2025-09-18BUY8931.85031.970 31.958USD 2,844 46.16
2025-09-17BUY26730.02032.800 32.522USD 8,683 46.26
2025-08-20SELL-35235.36036.470 36.359USD -12,798 46.52 Profit of 3,578 on sale
2025-07-30BUY1,15540.66041.710 41.605USD 48,054 46.88
2025-07-17SELL-17236.26037.760 37.610USD -6,469 47.38 Profit of 1,681 on sale
2025-07-11SELL-68839.93040.880 40.785USD -28,060 47.62 Profit of 4,704 on sale
2025-07-07BUY25839.41041.500 41.291USD 10,653 47.82
2025-07-02BUY4,73041.46042.430 42.333USD 200,235 47.91
2025-06-20BUY77942.02042.750 42.677USD 33,245 47.95
2025-06-11BUY16844.18045.970 45.791USD 7,693 48.25
2025-06-10BUY16845.70045.790 45.781USD 7,691 48.27
2025-06-04SELL-8443.17043.560 43.521USD -3,656 48.42 Profit of 411 on sale
2025-04-23BUY8440.05042.020 41.823USD 3,513 50.72
2025-04-10SELL-66441.90043.020 42.908USD -28,491 51.69 Profit of 5,830 on sale
2025-04-08SELL-8338.60041.620 41.318USD -3,429 51.92 Profit of 880 on sale
2025-04-07SELL-8339.90042.580 42.312USD -3,512 52.06 Profit of 809 on sale
2025-04-04SELL-42041.92043.120 43.000USD -18,060 52.18 Profit of 3,857 on sale
2025-04-01BUY85643.09044.970 44.782USD 38,333 52.39
2025-03-31SELL-24644.62044.700 44.692USD -10,994 52.48 Profit of 1,916 on sale
2025-03-21BUY1,36846.26047.440 47.322USD 64,736 52.95
2025-03-14SELL-1,24845.38047.160 46.982USD -58,634 53.39 Profit of 7,994 on sale
2025-03-07SELL-15449.56050.360 50.280USD -7,743 53.84 Profit of 547 on sale
2025-03-04SELL-7751.14052.060 51.968USD -4,002 53.99 Profit of 156 on sale
2025-02-25BUY15452.52052.700 52.682USD 8,113 54.24
2025-02-19SELL-7757.78058.160 58.122USD -4,475 54.25 Loss of -298 on sale
2025-02-13BUY23156.81057.260 57.215USD 13,217 54.02
2025-02-12BUY7756.02056.720 56.650USD 4,362 53.98
2025-02-11BUY30857.51058.470 58.374USD 17,979 53.91
2024-12-30SELL-2,93955.30056.970 56.803USD -166,944 51.78 Loss of -14,755 on sale
2024-11-18SELL-1,27552.89053.780 53.691USD -68,456 45.88 Loss of -9,961 on sale
2024-11-08SELL-8554.00054.470 54.423USD -4,626 44.58 Loss of -836 on sale
2024-10-21SELL-8641.18042.280 42.170USD -3,627 0.00 Loss of -3,627 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VCEL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19224,25038329,50268.1%
2025-09-18210,6424,505422,65649.8%
2025-09-17498,05718848,50058.7%
2025-09-16247,690103604,15841.0%
2025-09-15250,4542,198479,71752.2%
2025-09-12226,7730440,92151.4%
2025-09-11434,58001,188,98636.6%
2025-09-10217,5114507,03642.9%
2025-09-09154,9221,002432,14735.8%
2025-09-08119,0060262,99045.3%
2025-09-05205,6010280,26973.4%
2025-09-04194,4290640,87730.3%
2025-09-03164,172465276,64459.3%
2025-09-02115,4850201,16357.4%
2025-08-2979,4390137,36157.8%
2025-08-2873,1320128,83156.8%
2025-08-27224,056330450,38649.7%
2025-08-26220,3730479,25346.0%
2025-08-25109,6550154,17571.1%
2025-08-22231,2530366,46663.1%
2025-08-21270,34234,260440,51861.4%
2025-08-2061,16280088,72968.9%
2025-08-1955,65235083,44066.7%
2025-08-18223,2810397,65056.2%
2025-08-15152,7820279,45254.7%
2025-08-14121,23143191,22563.4%
2025-08-13155,5390317,59849.0%
2025-08-1299,1126,742139,27271.2%
2025-08-11127,4010226,59556.2%
2025-08-08108,4000153,58970.6%
2025-08-07158,721777213,18674.5%
2025-08-06144,941169222,68965.1%
2025-08-05113,3640155,46072.9%
2025-08-04202,1140265,40676.2%
2025-08-01209,3804,620311,18567.3%
2025-07-31458,9336,157947,63448.4%
2025-07-30201,101400266,95575.3%
2025-07-29156,11634217,86671.7%
2025-07-28126,81033181,31269.9%
2025-07-2566,0150116,39656.7%
2025-07-2498,110197186,19052.7%
2025-07-23190,5560299,77363.6%
2025-07-2294,5612,782216,24043.7%
2025-07-2198,7340243,03040.6%
2025-07-1890,83360240,25637.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.